{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:05:58Z","timestamp":1785805558213,"version":"3.56.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1093\/jac\/dkh479","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T01:13:26Z","timestamp":1101345206000},"page":"45-50","source":"Crossref","is-referenced-by-count":44,"title":["Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics"],"prefix":"10.1093","volume":"55","author":[{"given":"E.","family":"Presterl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Grisold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Reichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Hirschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Graninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,1]]},"reference":[{"key":"key\n\t\t\t\t20171010190842_R1","unstructured":"Bayer, A. S. & Scheld, W. M. (2000). Endocarditis and intravascular infections. In Principles and Practice of Infectious Diseases (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 857\u2013902. Churchill-Livingstone, Philadelphia, PA, USA."},{"key":"key\n\t\t\t\t20171010190842_R2","doi-asserted-by":"crossref","unstructured":"Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews15, 167\u201393.","DOI":"10.1128\/CMR.15.2.167-193.2002"},{"key":"key\n\t\t\t\t20171010190842_R3","doi-asserted-by":"crossref","unstructured":"Marron, A., Carratala, J., Gonzalez-Barca, E. et al. (2000). Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clinical Infectious Diseases31, 1126\u201330.","DOI":"10.1086\/317460"},{"key":"key\n\t\t\t\t20171010190842_R4","doi-asserted-by":"crossref","unstructured":"Ceri, H., Olson, M. E., Stremick, C. et al. (1999). The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology37, 1771\u20136.","DOI":"10.1128\/JCM.37.6.1771-1776.1999"},{"key":"key\n\t\t\t\t20171010190842_R5","doi-asserted-by":"crossref","unstructured":"Donlan, R. M. (2001). Biofilm formation: a clinically relevant microbiological process. Clinical Infectious Diseases33, 1387\u201392.","DOI":"10.1086\/322972"},{"key":"key\n\t\t\t\t20171010190842_R6","doi-asserted-by":"crossref","unstructured":"Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science284, 1318\u201322.","DOI":"10.1126\/science.284.5418.1318"},{"key":"key\n\t\t\t\t20171010190842_R7","doi-asserted-by":"crossref","unstructured":"Persson, L., Vikerfors, T., Sjoberg, L. et al. (2000). Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia. Scandinavian Journal of Infectious Diseases32, 615\u201321.","DOI":"10.1080\/003655400459513"},{"key":"key\n\t\t\t\t20171010190842_R8","doi-asserted-by":"crossref","unstructured":"Entenza, J. M., Que, Y. A., Vouillamoz, J. et al. (2001). Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrobial Agents and Chemotherapy45, 3076\u201383.","DOI":"10.1128\/AAC.45.11.3076-3083.2001"},{"key":"key\n\t\t\t\t20171010190842_R9","doi-asserted-by":"crossref","unstructured":"Durack, D. T., Bright, D. K. & Lukes, A. S. (1994). New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. American Journal of Medicine96, 200\u20139.","DOI":"10.1016\/0002-9343(94)90143-0"},{"key":"key\n\t\t\t\t20171010190842_R10","unstructured":"National Committee for Clinical Laboratory Standards. (2004). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010190842_R11","doi-asserted-by":"crossref","unstructured":"Reinert, R. R., Schlaeger, J. J. & Lutticken, R. (1998). Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy42, 803\u20136.","DOI":"10.1093\/jac\/42.6.803"},{"key":"key\n\t\t\t\t20171010190842_R12","doi-asserted-by":"crossref","unstructured":"Christensen, G. D., Simpson, W. A., Younger, J. J. et al. (1985). Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. Journal of Clinical Microbiology22, 996\u20131006.","DOI":"10.1128\/JCM.22.6.996-1006.1985"},{"key":"key\n\t\t\t\t20171010190842_R13","doi-asserted-by":"crossref","unstructured":"Baldassarri, L., Simpson, W. A., Donelli, G. et al. (1993). Variable fixation of staphylococcal slime by different histochemical fixatives. European Journal of Clinical Microbiology and Infectious Diseases12, 866\u20138.","DOI":"10.1007\/BF02000411"},{"key":"key\n\t\t\t\t20171010190842_R14","doi-asserted-by":"crossref","unstructured":"Li, Y. H., Lau, P. C., Tang, N. et al. (2002). Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans. Journal of Bacteriology184, 6333\u201342.","DOI":"10.1128\/JB.184.22.6333-6342.2002"},{"key":"key\n\t\t\t\t20171010190842_R15","doi-asserted-by":"crossref","unstructured":"Wen, Z. T. & Burne, R. A. (2002). Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Applied and Environmental Microbiology68, 1196\u2013203.","DOI":"10.1128\/AEM.68.3.1196-1203.2002"},{"key":"key\n\t\t\t\t20171010190842_R16","doi-asserted-by":"crossref","unstructured":"Francioli, P., Ruch, W. & Stamboulian, D. (1995). Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clinical Infectious Diseases21, 1406\u201310.","DOI":"10.1093\/clinids\/21.6.1406"},{"key":"key\n\t\t\t\t20171010190842_R17","doi-asserted-by":"crossref","unstructured":"Stewart, P. S. & Costerton, J. W. (2001). Antibiotic resistance of bacteria in biofilms. Lancet358, 135\u20138.","DOI":"10.1016\/S0140-6736(01)05321-1"},{"key":"key\n\t\t\t\t20171010190842_R18","doi-asserted-by":"crossref","unstructured":"Vella-Brincat, J. W., Begg, E. J., Gallagher, K. et al. (2004). Stability of benzylpenicillin during continuous home intravenous therapy. Journal of Antimicrobial Chemotherapy53, 675\u20137.","DOI":"10.1093\/jac\/dkh146"},{"key":"key\n\t\t\t\t20171010190842_R19","doi-asserted-by":"crossref","unstructured":"Shanson, D. C. (1998). New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. Journal of Antimicrobial Chemotherapy42, 292\u20136.","DOI":"10.1093\/jac\/42.3.292"},{"key":"key\n\t\t\t\t20171010190842_R20","doi-asserted-by":"crossref","unstructured":"Dailey, C. F., Dileto-Fang, C. L., Buchanan, L. V. et al. (2001). Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy45, 2304\u20138.","DOI":"10.1128\/AAC.45.8.2304-2308.2001"},{"key":"key\n\t\t\t\t20171010190842_R21","doi-asserted-by":"crossref","unstructured":"Gander, S., Hayward, K. & Finch, R. (2002). An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. Journal of Antimicrobial Chemotherapy49, 301\u20138.","DOI":"10.1093\/jac\/49.2.301"},{"key":"key\n\t\t\t\t20171010190842_R22","doi-asserted-by":"crossref","unstructured":"Pankey, G. A. & Sabath, L. D. (2004). Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clinical Infectious Diseases38, 864\u201370.","DOI":"10.1086\/381972"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/1\/45\/2332732\/dkh479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T08:29:14Z","timestamp":1585988954000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/1\/45\/776975\/Viridans-streptococci-in-endocarditis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh479","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2005,1,1]]}}}